Skip to content

Abnormalities of Preoperative Ascending Urethrocystography and Outcomes of Living Donor Kidney Transplantation

Effects of Abnormalities of Preoperative Ascending Urethrocystography on the Short-term Outcomes of Living Donor Kidney Transplantation

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06735066
Enrollment
80
Registered
2024-12-16
Start date
2024-12-31
Completion date
2025-11-01
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Transplantation

Keywords

preoperative ascending urethrocystography

Brief summary

To evaluate effects of abnormalities in preoperative ascending urethrocystography on the short-term outcomes of LDKT

Detailed description

The incidence of surgical complications after kidney transplantation (KT) has decreased in recent decades due to improvements in surgical techniques and immunosuppression protocols. However, the preoperative abnormalities of the urinary tract may influence the outcomes of KT. Hence, the preoperative evaluation of the urinary tract is a critical step in the KT process to identify the potential risk factors for poor outcomes . Ascending urethrocystography (AUC) is a key diagnostic tool to assess the integrity and functionality of the lower urinary tract . It provides detailed insights into the bladder, urethra, vesicoureteral valves, and surrounding structures, identifying any abnormalities that could pose risks during or after KT . Understanding this issue is crucial, as certain urological anomalies may predispose patients to complications such as urinary leaks, infections, or delayed graft function, potentially leading to poorer short-term outcomes . Although AUC is used indiscriminately as a screening test for urological abnormalities, only 6% of all KT recipients may have abnormal lower urinary tract . Few studies have looked at the yield from AUC and attempted to assess objectively whether certain patients could be selected for KT based on a positive result in AUC . Accordingly, the impact of abnormalities detected in AUC on the short-term outcomes of living donor KT (LDKT) remains inefficiently studied . This is the rationale to conduct this cohort study on patients undergoing LDKT. We hypothesize that the presence of abnormalities in AUC will influence the surgical outcomes and short-term survival rates after LDKT

Interventions

PROCEDUREAscending urethrocystography

It will be performed after instructing the patient to evacuate the bladder. A contrast agent will be infused through the urethra under fluoroscopy, using a urethral catheter or Knutson's clamp at the external urethral meatus. When the bladder is full, an anteroposterior film and two oblique films will be taken. Voiding cystourethrography will be performed as a part of this imaging examination. From this procedure, the following findings may be diagnosed: * Upper urinary tract: Vesicoureteral reflux (VUR); laterality and degrees of VUR will be defined. * Bladder: Capacity (defunctionalized, Small-sized or contracted bladder), neurogenic bladder, bladder diverticulum, filling defects, etc. * Urethra: Stricture and filling defects.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
5 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Pediatric and adult patients undergoing LDKT in Assiut Kidney Transplantation Unit. * Patients with preoperative evaluation by AUC.

Exclusion criteria

* Patients with a primary non-functioning graft after LDKT. * Patients with missing relevant preoperative or postoperative data. * Patients refusal to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
The incidence of urinary complications post kidney transplantation6 monthEach patient will be followed up for the surgical complications for 6- month duration after KT

Contacts

Primary ContactShehabeldin Saad
shehab.16266285@med.aun.edu.eg+201067076462

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026